Abbott Laboratories Operating Margin vs. Current Valuation

ABTT34 Stock  BRL 59.80  0.04  0.07%   
Based on Abbott Laboratories' profitability indicators, Abbott Laboratories may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Abbott Laboratories' ability to earn profits and add value for shareholders.
For Abbott Laboratories profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Abbott Laboratories to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Abbott Laboratories utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Abbott Laboratories's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Abbott Laboratories over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
For information on how to trade Abbott Stock refer to our How to Trade Abbott Stock guide.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abbott Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Abbott Laboratories Current Valuation vs. Operating Margin Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Abbott Laboratories's current stock value. Our valuation model uses many indicators to compare Abbott Laboratories value to that of its competitors to determine the firm's financial worth.
Abbott Laboratories is number one stock in operating margin category among its peers. It also is the top company in current valuation category among its peers reporting about  5,318,915,173,000  of Current Valuation per Operating Margin. Comparative valuation analysis is a catch-all model that can be used if you cannot value Abbott Laboratories by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Abbott Laboratories' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Abbott Current Valuation vs. Operating Margin

Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Abbott Laboratories

Operating Margin

 = 

Operating Income

Revenue

X

100

 = 
0.20 %
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Abbott Laboratories

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
1.07 T
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

Abbott Current Valuation vs Competition

Abbott Laboratories is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Medical Devices industry is presently estimated at about 4.56 Trillion. Abbott Laboratories totals roughly 1.07 Trillion in current valuation claiming about 23% of all equities under Medical Devices industry.

Abbott Laboratories Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Abbott Laboratories, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Abbott Laboratories will eventually generate negative long term returns. The profitability progress is the general direction of Abbott Laboratories' change in net profit over the period of time. It can combine multiple indicators of Abbott Laboratories, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company was founded in 1888 and is based in North Chicago, Illinois. ABBOTT DRN operates under Medical Devices classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 109000 people.

Abbott Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Abbott Laboratories. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Abbott Laboratories position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Abbott Laboratories' important profitability drivers and their relationship over time.

Use Abbott Laboratories in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbott Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will appreciate offsetting losses from the drop in the long position's value.

Abbott Laboratories Pair Trading

Abbott Laboratories Pair Trading Analysis

The ability to find closely correlated positions to Abbott Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbott Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbott Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbott Laboratories to buy it.
The correlation of Abbott Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbott Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbott Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbott Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Abbott Laboratories position

In addition to having Abbott Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Aircraft Thematic Idea Now

Aircraft
Aircraft Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Aircraft theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aircraft Theme or any other thematic opportunities.
View All  Next Launch

Additional Information and Resources on Investing in Abbott Stock

When determining whether Abbott Laboratories is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Abbott Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Abbott Laboratories Stock. Highlighted below are key reports to facilitate an investment decision about Abbott Laboratories Stock:
Check out Trending Equities.
For information on how to trade Abbott Stock refer to our How to Trade Abbott Stock guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
To fully project Abbott Laboratories' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Abbott Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Abbott Laboratories' income statement, its balance sheet, and the statement of cash flows.
Potential Abbott Laboratories investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Abbott Laboratories investors may work on each financial statement separately, they are all related. The changes in Abbott Laboratories's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Abbott Laboratories's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.